MARKETVOLUME®

www.MarketVolume.com

Technical Analysis - OREXIGEN THERAPEUTICS (Stock Symbol: OREX)

OREX Stock's Performance


     

The performance tables below will allow you to compare the performance of the OREXIGEN THERAPEUTICS (OREX) stock and the S&P 500 Index(^SPX) (you may select other index from the list below). We provide performance comparison for the most recent trading session, for the past month (30 days) for 52 weeks (1-year) and YTD.

Several timeframes help evaluating whether current OREX stock's performance is in the range of the average yearly, monthly or YTD performance. The "Ratio (%)" is calculated as a ration between SPX index and OREX stock data. Since SPX index and OREX stock prices are in different range the "Ratio (%)" helps to compare SPX index and OREX stock performances. At the same time the "Ratio (%)" allows to see what percentage of index's volume (if OREX stock is listed in the SPX index) belongs to the OREX stock.


Compare and OREXIGEN THERAPEUTICS (OREX) stock.
Delayed Quotes - U.S. Markets Closed.

Today's Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
Last Trade0.00 Last Trade6.66
Trade Time (ET)01/16/2014 11:31 Trade Time (ET)01/16/2014 11:31
Change0.00 Change0.10(1.48%)2.66
Previous Close0.00 Previous Close6.76
Open0.00 Open6.75
High0.00 High6.82
Low0.00 Low6.63
VolumeSign Up K Volume949 K

1-Month Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
1-month Change0.00 1-month Change0.10(1.48%)2.66
1-month High0.00 1-month High0.00
1-month Low0.00 1-month Low0.00
Average Daily VolumeSign Up K Average Daily Volume0 K
Average Daily Change0.00 % Average Daily Change0.00 %

YTD Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
YTD Change0.00 YTD Change1.03(18.29%)-27.76
YTD High0.00 YTD High6.82
YTD Low0.00 YTD Low5.48
Average Daily VolumeSign Up K Average Daily Volume2,752 K
Average Daily Change0.00 % Average Daily Change2.68 %

52-week (1 year) Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
52-week Change0.00 52-week Change0.05(0.75%)-0.04
52-week High0.00 52-week High7.05
52-week Low0.00 52-week Low4.59
Average Daily VolumeSign Up K Average Daily Volume2,096 K
Average Daily Change0.00 % Average Daily Change2.82 %
 
About S&P 500 Index(^SPX)

The S&P 500 ("Standard & Poor's 500 Stock Index") is widely regarded as the standard for measuring large-cap U.S. stock market performance. This is one of the most popular indexes representing the top 500 companies in leading industries (most of them listed on the New York Stock Exchange).
About OREXIGEN THERAPEUTICS (OREX)

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
Disclaimer | Privacy © 1997-2013 MarketVolume.com. All Rights Reserved. SV1
Charts
Stocks & ETFs
Indexes
Advance Decline
Knowledge Base
Trading Systems
News

© 1997-2014 www.MarketVolume.com. All Rights Reserved.